• Western blot analysis of extracts from wild type (WT) and FOXN2 knockout (KO) HeLa (KO) cells, using FOXN2 antibody (STJ11104899) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.

Anti-FOXN2 antibody (204-431 aa) [S4899RM] (STJ11104899)

SKU:
STJ11104899

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB/ELISA
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality: Monoclonal
Clone ID: S4899RM
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.05% Proclin300, 0.05% BSA, 50% Glycerol, pH 7.3.
Purification: Affinity purification
Concentration: Lot specific
Dilution Range: WB:1:500-1:1000
ELISA:Recommended starting concentration is 1 Mu g/mL. Please optimize the concentration based on your specific assay requirements.
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: FOXN2
Gene ID: 3344
Uniprot ID: FOXN2_HUMAN
Immunogen Region: 204-431 aa
Specificity: Recombinant fusion protein containing a sequence corresponding to amino acids 204-431 of human FOXN2. (NP_002149.2).
Immunogen Sequence: QPFSSASSQNGSLSPHYLSS VIKQNQVRNLKESDIDAAAA MMLLNTSIEQGILECEKPLP LKTALQKKRSYGNAFHHPSA VRLQESDSLATSIDPKEDHN YSASSMAAQRCASRSSVSSL SSVDEVYEFIPKNSHVGSDG SEGFHSEEDTDVDYEDDPLG DSGYASQPCAKISEKGQSGK KMRKQTCQEIDEELKEAAGS LLHLAGIRTCLGSLISTAKT QNQKQRKK
Function Binds to the purine-rich region in HTLV-I LTR.
Protein Name Forkhead Box Protein N2
Human T-Cell Leukemia Virus Enhancer Factor
Cellular Localisation Nucleus
Alternative Antibody Names Anti-Forkhead Box Protein N2 antibody
Anti-Human T-Cell Leukemia Virus Enhancer Factor antibody
Anti-FOXN2 antibody
Anti-HTLF antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance